In the second part, we discuss how to predict the effect of TACE "bridging" therapy for liver cancer beyond Milan's standard by using imaging omics features, and establish a prediction model. The third part, establish and verify the nomogram prediction model of TACE "bridging" related liver cancer recurrence beyond Milan standard after transplantation.
正在翻译中..